BioCentury
ARTICLE | Clinical News

GLPG2222: Phase I started

February 1, 2016 8:00 AM UTC

Galapagos began a double-blind, placebo-controlled, Belgian Phase I trial to evaluate single and multiple ascending doses of oral GLPG2222 in about 40 healthy volunteers. The trial start triggered a $...